Vascular Dynamics
Vascular Dynamics is a clinical-stage medical device company developing the MobiusHD, an implantable device that reshapes the carotid artery to enhance cardiovascular regulation for heart failure treatment.
- Company typePrivate
- Founded2008
- HeadquartersMountain View, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Vascular Dynamics firmographics
Firmographics- Name
- Vascular Dynamics
- Website
- https://vasculardynamics.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vascular Dynamics is a clinical-stage medical device company developing the MobiusHD, an implantable device that reshapes the carotid artery to enhance cardiovascular regulation for heart failure treatment.
- Ownership category
- akta.pro rank
Vascular Dynamics industry classification
Industry- Product category
- Cardiovascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industries
- Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH), Heart Failure & Transplant Cardiology (HLAKABAD)
Keywords
Where Vascular Dynamics is headquartered
LocationHeadquarters
- HQ city
- Mountain View
- HQ country
- United States
- HQ region
- North America
Markets served
Vascular Dynamics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- MobiusHD Device Sales: Pre-commercial medical device company. Revenue model not yet established - the company recently completed $20M equity financing to fund clinical evaluations and pivotal trials. Once commercialized, expected to generate revenue through one-time device sales to healthcare providers treating heart failure patients.
Go-to-market motion1 record
Vascular Dynamics product offering
Product offeringCore offering
Vascular Dynamics develops the MobiusHD device, an implantable stent-like medical device designed to reshape the carotid artery in order to enhance the body's natural cardiovascular regulation. The device is intended for the treatment of resistant hypertension and heart failure, offering a mechanical intervention alternative for patients who do not respond adequately to pharmaceutical therapies. The company is currently advancing the product through expanded clinical evaluations and pivotal trials in preparation for regulatory approval and commercialization.
Differentiator
Problem solved
Functional benefit
Products and services
- MobiusHD
Quantifiable outcome
- Promising initial results in clinical evaluations leading to expanded studies and pivotal trials
Companies that use Vascular Dynamics
Customer profileSegments1 record
Ideal customer profiles1 record
Vascular Dynamics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Vascular Dynamics partnerships and signals
Strategic signalScale indicators1 record
Vascular Dynamics competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic operates a large cardiovascular portfolio across heart failure, structural heart, and cardiac surgery devices. Comparable as the dominant incumbent setting reimbursement and standard-of-care benchmarks against which a novel HF device like MobiusHD must compete.
- Edwards Lifesciences: Edwards is a leader in structural heart and critical care monitoring with growing investment in heart failure. It represents a likely strategic acquirer profile and a benchmark for premium medtech valuations in cardiac care.
- Boston Scientific: Boston Scientific offers WATCHMAN, structural heart devices, and a peripheral/vascular intervention portfolio. It is a broad incumbent comparable for cardiovascular implant commercialization and global launch infrastructure.
- CardioMEMS (now Abbott): CardioMEMS HF System is an implantable pulmonary artery pressure sensor for remote heart failure monitoring. Comparable as an implantable device addressing heart failure management through a novel mechanism, validating the strategic value of HF device assets.
- Abbott: Abbott markets HeartMate 3 LVAD and a broad cardiovascular portfolio including heart failure diagnostics and structural heart devices. It is a broad incumbent comparator for company-building and eventual strategic-acquirer dynamics.
Emerging players
- Respicardia: Respicardia's remedē System is an implantable neurostimulation device for central sleep apnea, a condition highly prevalent in heart failure patients. Comparable as a small-cap implantable device targeting HF-adjacent indications with similar regulatory and commercial dynamics.
- Axonics: Axonics develops implantable neuromodulation devices (sacral and tibial) for urological and bowel disorders. It is comparable as a small-cap implantable neuromodulation company with similar regulatory, manufacturing, and clinical-trial execution profiles.
- BackBeat Medical: BackBeat Medical is developing cardiac stimulation-based therapies for hypertension and heart failure. Comparable as a small emerging player in device-based modulation of cardiovascular regulation pathways with overlapping target mechanisms.
Direct peers
- Recor Medical: Recor Medical is developing the Paradise ultrasound renal denervation system for hypertension and is expanding into heart failure indications. It is a direct peer in device-based neuromodulation for cardiovascular disease with overlapping target patient populations.
- CVRx: CVRx develops Barostim, an implantable device that uses electrical stimulation of the carotid baroreceptors to treat heart failure. It is the closest direct peer to Vascular Dynamics, both targeting heart failure via neuromodulation/mechanical intervention at the carotid sinus.
Market position
Customer concentration
Vascular Dynamics social profiles
Digital presenceVascular Dynamics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vascular Dynamics leadership team
Management profileNumber of profiles
Profiles2 records
Vascular Dynamics funding detail
Funding detailFunding overview
Funding rounds10 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vascular Dynamics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vascular Dynamics
What does Vascular Dynamics do?
Vascular Dynamics develops the MobiusHD device, an implantable stent-like medical device designed to reshape the carotid artery in order to enhance the body's natural cardiovascular regulation. The device is intended for the treatment of resistant hypertension and heart failure, offering a mechanical intervention alternative for patients who do not respond adequately to pharmaceutical therapies. The company is currently advancing the product through expanded clinical evaluations and pivotal trials in preparation for regulatory approval and commercialization.
Is Vascular Dynamics a public or private company?
Vascular Dynamics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vascular Dynamics founded?
Vascular Dynamics was founded in 2008. It employs 11 to 50 people.
Where is Vascular Dynamics based?
Vascular Dynamics is headquartered in Mountain View, United States, in the North America region.
How does Vascular Dynamics make money?
One revenue line is on record: mobiusHD Device Sales.
Who are Vascular Dynamics's main competitors?
Broad incumbents on record are Medtronic, Edwards Lifesciences, Boston Scientific, CardioMEMS (now Abbott) and Abbott. Emerging players are Respicardia, Axonics and BackBeat Medical. Direct peers are Recor Medical and CVRx.
Does Vascular Dynamics have an API?
No public API is recorded for Vascular Dynamics.
What industry is Vascular Dynamics in?
Vascular Dynamics's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts). Its NAICS code is 339112 and its SIC code is 3841.